Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ICOSLG anticorps (AA 23-149)

L’anticorps Souris Monoclonal anti-ICOSLG a été validé pour ELISA, IHC, Coat, StM et ISt. Il convient pour détecter ICOSLG dans des échantillons de Humain.
N° du produit ABIN6939408

Aperçu rapide pour ICOSLG anticorps (AA 23-149) (ABIN6939408)

Antigène

Voir toutes ICOSLG Anticorps
ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

Reactivité

  • 87
  • 16
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 45
  • 45
  • 8
  • 1
Souris

Clonalité

  • 59
  • 39
  • 1
Monoclonal

Conjugué

  • 56
  • 9
  • 7
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp ICOSLG est non-conjugé

Application

  • 45
  • 39
  • 35
  • 33
  • 18
  • 16
  • 6
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (IHC), Coating (Coat), Staining Methods (StM), Immunostaining (ISt)

Clone

ICOSL-3260
  • Épitope

    • 21
    • 7
    • 5
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 23-149

    Specificité

    This MAb recognizes a protein of 36 kDa, identified as ICOS-L. It is a ligand for the ICOS receptor that initiates T and B cell proliferation and cytokine secretion. ICOS-L interactions play an essential role in T cell-dependent B cell activation in peripheral lymphoid organs such as spleen and lymph nodes. ICOS-L protein is present in myeloid leukocytes, and by Northern blot there are 2.4, 3.0, and 7.0 kb transcripts in brain, heart, kidney, and liver, with lower expression in colon and thymus, and a 1.1 kb transcript in leukocytes. Tumor necrosis factor alpha (TNF), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) enhance its expression. LPS-induced up-regulation of ICOS-L is dependent on the MyD88-dependent signaling pathway.

    Purification

    Purified by Protein A/G

    Immunogène

    Recombinant fragment of human ICOSLG (B7RP-1) protein (around aa 23-149) (exact sequence is proprietary)

    Isotype

    IgG2b kappa
  • Indications d'application

    Positive Control: HL60, HuT78 and HUVEC cells. Prostate or Colon Carcinoma.

    Known Application: ELISA (For coating, order antibody without BSA),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

    Autre désignation

    ICOSLG

    Poids moléculaire

    36kDa

    ID gène

    23308

    UniProt

    O75144

    Pathways

    Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Vous êtes ici:
Chat with us!